Will Delays In Launch Of Amneal’s Generic NuvaRing Help Dr. Reddy’s?
Products of Dr. Reddy’s Laboratories at one of its facilities in Hyderabad. Teva Pharma and Mayne Pharma, as well as Amneal and Dr. Reddy’s, have filed their applications with the US FDA to launch the NuvaRing generic in the U.S. (Photographer: Scott Eells/Bloomberg News)

Will Delays In Launch Of Amneal’s Generic NuvaRing Help Dr. Reddy’s?

Amneal Pharmaceuticals Inc. has said its planned launch of key generics, including a female contraceptive, in the U.S. is facing delays. That may be a window of opportunity for Dr. Reddy’s Laborato...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.